www.fdanews.com/articles/123705-intelgenx-changes-manufacturing-site-for-cpi-300

IntelGenx Changes Manufacturing Site for CPI-300

January 15, 2010

IntelGenx Corp. announced a manufacturing site change for its antidepressant CPI-300, which it developed with Cary Pharmaceuticals.
CNNMoney